Update on the epidemiology of Paget's disease of bone
- PMID: 17229005
- DOI: 10.1359/jbmr.06s201
Update on the epidemiology of Paget's disease of bone
Abstract
Paget's disease of bone (PDB) is characterized by rapid bone remodeling and the formation of bone that is structurally abnormal. Recent studies have confirmed that both genetic and environmental factors are important in its etiology. Epidemiological studies in Europe and North America have revealed that PDB shows an increasing frequency of occurrence with age and is more prevalent among men than women. There is marked geographic variation in the prevalence of PDB throughout western nations, with the highest rates reported during the 1970s in Britain. Recent studies of the secular trends in PDB suggest declining rates in both prevalence and severity at diagnosis. Thus, the overall age/sex standardized prevalence rate in Britain during the period 1993-1995 was found to be 2.5% among men and 1.6% among women > or = 55 years of age. Prevalence rates had fallen by approximately 50% in several of the centers studied, suggesting an environmental contribution to the etiology of this disorder. Similar findings have been reported from other European countries and New Zealand. Recent study of the incidence and clinical manifestations of PDB have emerged from large cohort studies in primary care record linkage resources, such as the General Practice Research Database. Over the period 1988-1999, the incidence rate of clinically diagnosed PDB was found to be 5 per 10,000 person-years among men and 3 per 10,000 person-years among women 75 years of age. The disorder was associated with an increased risk of back pain (RR, 2.1; 95% CI, 1.9-2.3); osteoarthritis (RR, 1.7; 95% CI, 1.5-1.9); and fracture (RR, 1.2; 95% CI, 1.0-1.5). Using life table methodology, the estimated proportion of patients dying within 5 years of follow-up was 32.7% among the cohort with PDB compared with 28.0% among control patients (p < 0.05).
Similar articles
-
Incidence and natural history of Paget's disease of bone in England and Wales.J Bone Miner Res. 2002 Mar;17(3):465-71. doi: 10.1359/jbmr.2002.17.3.465. J Bone Miner Res. 2002. PMID: 11878305
-
Epidemiology of Paget's disease of bone.Bone. 1999 May;24(5 Suppl):3S-5S. doi: 10.1016/s8756-3282(99)00023-x. Bone. 1999. PMID: 10321916 Review. No abstract available.
-
The Changing Presentation of Paget's Disease of Bone in Australia, A High Prevalence Region.Calcif Tissue Int. 2017 Dec;101(6):564-569. doi: 10.1007/s00223-017-0312-1. Epub 2017 Sep 7. Calcif Tissue Int. 2017. PMID: 28884211
-
The Decline of Paget's Disease of Bone and Domestic Coal Use-A Hypothesis.Calcif Tissue Int. 2024 Aug;115(2):117-123. doi: 10.1007/s00223-024-01241-0. Epub 2024 Jun 20. Calcif Tissue Int. 2024. PMID: 38902530 Free PMC article. Review.
-
Prevalence and incidence of Paget's disease of bone: Temporal trend over 20 years in the province of Quebec, Canada.Bone. 2023 Nov;176:116895. doi: 10.1016/j.bone.2023.116895. Epub 2023 Sep 6. Bone. 2023. PMID: 37683713
Cited by
-
Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data.Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1616-1626. doi: 10.1002/pds.5103. Epub 2020 Sep 7. Pharmacoepidemiol Drug Saf. 2020. PMID: 32894794 Free PMC article.
-
A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.Hum Mol Genet. 2008 Dec 1;17(23):3708-19. doi: 10.1093/hmg/ddn266. Epub 2008 Sep 2. Hum Mol Genet. 2008. PMID: 18765443 Free PMC article.
-
Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone.J Bone Miner Metab. 2008;26(6):635-41. doi: 10.1007/s00774-008-0852-6. Epub 2008 Nov 1. J Bone Miner Metab. 2008. PMID: 18979164 Clinical Trial.
-
Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.Osteoporos Int. 2018 Sep;29(9):2011-2020. doi: 10.1007/s00198-018-4386-z. Epub 2018 Jul 16. Osteoporos Int. 2018. PMID: 30014158
-
Emerging strategies and therapies for treatment of Paget's disease of bone.Drug Des Devel Ther. 2011;5:225-39. doi: 10.2147/DDDT.S11306. Epub 2011 Apr 26. Drug Des Devel Ther. 2011. PMID: 21607019 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical